-
1
-
-
0034126818
-
Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania
-
DOI 10.1097/00003226-200005000-00010
-
Tanure MA, Cohen EJ, Sudesh S, et al. Spectrum of fungal keratitis at Wills Eye Hospital. Philadelphia, Pennsylvania. Cornea 2000;19:307-12. (Pubitemid 30322454)
-
(2000)
Cornea
, vol.19
, Issue.3
, pp. 307-312
-
-
Tanure, M.A.G.1
Cohen, E.J.2
Sudesh, S.3
Rapuano, C.J.4
Laibson, P.R.5
-
2
-
-
0028227629
-
The changing spectrum of fungal keratitis in South Florida
-
Rosa RH Jr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology 1994;101:1005-13. (Pubitemid 24183155)
-
(1994)
Ophthalmology
, vol.101
, Issue.6
, pp. 1005-1013
-
-
Rosa Jr., R.H.1
Miller, D.2
Alfonso, E.C.3
-
3
-
-
0025157858
-
Microbial keratitis after penetrating keratoplasty
-
Bates AK, Kirkness CM, Ficker LA, et al. Microbial keratitis after penetrating keratoplasty. Eye 1990;4:74-8.
-
(1990)
Eye
, vol.4
, pp. 74-78
-
-
Bates, A.K.1
Kirkness, C.M.2
Ficker, L.A.3
-
4
-
-
0023715076
-
Microbial keratitis complicating penetrating keratoplasty
-
Fong LP, Ormerod LD, Kenyon KR, et al. Microbial keratitis complicating penetrating keratoplasty. Ophthalmology 1988;95:1269-75.
-
(1988)
Ophthalmology
, vol.95
, pp. 1269-1275
-
-
Fong, L.P.1
Ormerod, L.D.2
Kenyon, K.R.3
-
5
-
-
0023769550
-
Late bacterial and fungal keratitis after corneal transplantation. Spectrum of pathogens, graft survival, and visual prognosis
-
Harris DJ, Stulting RD, Waring GO, et al. Late bacterial and fungal keratitis after corneal transplantation. Spectrum of pathogens, graft survival, and visual prognosis. Ophthalmology 1988;95:1450-7.
-
(1988)
Ophthalmology
, vol.95
, pp. 1450-1457
-
-
Harris, D.J.1
Stulting, R.D.2
Waring, G.O.3
-
6
-
-
0034782339
-
Infectious keratitis after penetrating keratoplasty
-
Tixier J, Bourcier T, Borderie V, et al. Infectious keratitis after penetrating keratoplasty. J Fr Ophthalmol 2001;24:597-602.
-
(2001)
J Fr Ophthalmol
, vol.24
, pp. 597-602
-
-
Tixier, J.1
Bourcier, T.2
Borderie, V.3
-
7
-
-
0242407349
-
Bilateral Candida parapsilosis interface keratitis after laser in situ keratomileusis
-
DOI 10.1016/S0886-3350(03)00217-7
-
Muallem MS, Alfonso EC, Romano AC, et al. Bilateral Candida parapsilosis interface keratitis after laser in situ keratomileusis. J Cataract Refract Surg 2003;29:2022-5. (Pubitemid 37385977)
-
(2003)
Journal of Cataract and Refractive Surgery
, vol.29
, Issue.10
, pp. 2022-2025
-
-
Muallem, M.S.1
Alfonso, E.C.2
Romano, A.C.3
Miller, D.4
Kurstin, J.5
Marangon, F.B.6
Culbertson, W.W.7
Yoo, S.H.8
-
8
-
-
0033997683
-
Fungal keratitis after laser in situ keratomileusis
-
DOI 10.1016/S0886-3350(99)00459-9, PII S0886335000004599
-
Sridhar MS, Garg P, Bansal AK, et al. Fungal keratitis after laser in situ keratomileusis. J Cataract Refract Surg 2000;26:613-15. (Pubitemid 30213264)
-
(2000)
Journal of Cataract and Refractive Surgery
, vol.26
, Issue.4
, pp. 613-615
-
-
Sridhar, M.S.1
Garg, P.2
Bansal, A.K.3
Sharma, S.4
-
10
-
-
0026004973
-
Influence of corticosteroid on experimentally induced keratomycosis
-
O'Day DM, Ray WA, Head WS, et al. Influence of corticosteroid on experimentally induced keratomycosis. Arch Ophthalmol 1991;109:1601-4.
-
(1991)
Arch Ophthalmol
, vol.109
, pp. 1601-1604
-
-
O'Day, D.M.1
Ray, W.A.2
Head, W.S.3
-
11
-
-
0032912261
-
Effects of methylprednisolone and cyclosporine A on fungal growth in vitro
-
DOI 10.1097/00003226-199905000-00012
-
Bell NP, Karp CL, Alfonso EC, et al. Effects of methylprednisolone and cyclosporine A on fungal growth in vitro. Cornea 1999;18:306-13. (Pubitemid 29205557)
-
(1999)
Cornea
, vol.18
, Issue.3
, pp. 306-313
-
-
Bell, N.P.1
Karp, C.L.2
Alfonso, E.C.3
Schiffman, J.4
Miller, D.5
-
12
-
-
0029952398
-
Topical fluconazole therapy of Candida keratitis
-
DOI 10.1097/00003226-199607000-00007
-
Panda A, Sharma N, Angra SK. Topical fluconazole therapy of Candida keratitis. Cornea 1996;15:373-5. (Pubitemid 26189977)
-
(1996)
Cornea
, vol.15
, Issue.4
, pp. 373-375
-
-
Panda, A.1
Sharma, N.2
Angra, S.K.3
-
14
-
-
0346327201
-
Fungal infections of the cornea
-
DOI 10.1038/sj.eye.6700557
-
Thomas PA. Fungal infections of the cornea. Eye 2003;17:852-62. (Pubitemid 37541037)
-
(2003)
Eye
, vol.17
, Issue.8
, pp. 852-862
-
-
Thomas, P.A.1
-
15
-
-
0026028353
-
Fluconazole: A new antifungal agent
-
Kowalsky SF, Dixon DM. Fluconazole: a new antifungal agent. Clin Pharm 1991;10:179-94.
-
(1991)
Clin Pharm
, vol.10
, pp. 179-194
-
-
Kowalsky, S.F.1
Dixon, D.M.2
-
17
-
-
0025122080
-
Amphotericin B: Current understanding of mechanisms of action
-
Brajtburg J, Powderly WG, Kobayashi GS, et al. Amphotericin B: current understanding of mechanisms of action. Antimicrob Agents Chemother 1990;34:183-8. (Pubitemid 20046861)
-
(1990)
Antimicrobial Agents and Chemotherapy
, vol.34
, Issue.2
, pp. 183-188
-
-
Brajtburg, J.1
Powderly, W.G.2
Kobayashi, G.S.3
Medoff, G.4
-
18
-
-
0141863188
-
Echinocandin antifungal drugs
-
DOI 10.1016/S0140-6736(03)14472-8
-
Denning DW. Echinocandin antifungal drugs. Lancet 2003;362:1142-51. (Pubitemid 37222342)
-
(2003)
Lancet
, vol.362
, Issue.9390
, pp. 1142-1151
-
-
Denning, D.W.1
-
19
-
-
0035147071
-
Update on antifungals targeted to the cell wall: Focus on beta-1,3-glucan synthase inhibitors
-
DOI 10.1517/13543784.10.2.269
-
Georgopapadakou NH. Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors. Expert Opin Investig Drugs 2001;10:269-80. (Pubitemid 32117936)
-
(2001)
Expert Opinion on Investigational Drugs
, vol.10
, Issue.2
, pp. 269-280
-
-
Georgopapadakou, N.H.1
-
20
-
-
0034076997
-
Efficacy of FK463, a (1,3)-b-D-glucan synthase inhibitor, in disseminated azole-resistant Candida albicans infection in mice
-
DOI 10.1128/AAC.44.6.1728-1730.2000
-
Maesaki S, Hossain MA, Miyazaki Y, et al. Efficacy of FK463, a (1,3)-b-D-glucan synthase inhibitor, disseminated azole-resistant Candida albicans infection in mice. Antimicrob Agents Chemother 2000;44:1728-30. (Pubitemid 30340827)
-
(2000)
Antimicrobial Agents and Chemotherapy
, vol.44
, Issue.6
, pp. 1728-1730
-
-
Maesaki, S.1
Hossain, M.A.2
Miyazaki, Y.3
Tomono, K.4
Tashiro, T.5
Kohno, S.6
-
21
-
-
0042134553
-
The echinocandin antifungals: An overview of the pharmacology, spectrum and clinical efficacy
-
Wiederhold NP, Lewis RE. The echinocandin antifungals: an overview of the pharmacology, spectrum and clinical efficacy. Expert Opin Investig Drugs 2003;12:1313-33.
-
(2003)
Expert Opin Investig Drugs
, vol.12
, pp. 1313-1333
-
-
Wiederhold, N.P.1
Lewis, R.E.2
-
22
-
-
0142119307
-
Antifungal activity and clinical efficacy of micafungin sodium (Funguard)
-
DOI 10.1254/fpj.122.339
-
Ikeda F. Antifungal activity and clinical efficacy of micafungin sodium (Funguard). Nippon Yakurigaku Zasshi 2003;122:339-44. (Pubitemid 37295655)
-
(2003)
Folia Pharmacologica Japonica
, vol.122
, Issue.4
, pp. 339-344
-
-
Ikeda, F.1
-
23
-
-
0036372571
-
Morphological changes of Candida albicans induced by micafungin (FK463), a water-soluble echinocandin-like lipopeptide
-
DOI 10.1093/jmicro/51.4.247
-
Nishiyama Y, Uchida K, Yamaguchi H. Morphological changes of Candida albicans induced by micafungin (FK463), a water-soluble echinocandin-like lipopeptide. J Electron Microsc 2002;51:247-55. (Pubitemid 34979146)
-
(2002)
Journal of Electron Microscopy
, vol.51
, Issue.4
, pp. 247-255
-
-
Nishiyama, Y.1
Uchida, K.2
Yamaguchi, H.3
-
24
-
-
0038440777
-
Killing activity of micafungin against Aspergillus fumigatus hyphae assessed by specific fluorescent staining for cell viability
-
DOI 10.1128/AAC.47.6.1995-1998.2003
-
Watabe E, Nakai T, Matsumoto S, et al. Killing activity of micafungin against Aspergillus fumigatus hyphae assessed by specific fluorescent staining for cell viability. Antimicrob Agents Chemother 2003;47:1995-8. (Pubitemid 36637830)
-
(2003)
Antimicrobial Agents and Chemotherapy
, vol.47
, Issue.6
, pp. 1995-1998
-
-
Watabe, E.1
Nakai, T.2
Matsumoto, S.3
Ikeda, F.4
Hatano, K.5
-
25
-
-
4544236835
-
A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients
-
DOI 10.1086/423377
-
De Wet N, Llanos-Cuentas A, Suleiman J, et al. A randomized, double-blind, parallelgroup, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients. Clin Infect Dis 2004;39:842-9. (Pubitemid 39244300)
-
(2004)
Clinical Infectious Diseases
, vol.39
, Issue.6
, pp. 842-849
-
-
De Wet, N.1
Llanos-Cuentas, A.2
Suleiman, J.3
Baraldi, E.4
Krantz, E.F.5
Della, N.M.6
Diekmann-Berndt, H.7
-
26
-
-
20144387002
-
A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis
-
DOI 10.1111/j.1365-2036.2005.02427.x
-
De Wet NT, Bester AJ, Viljoen JJ, et al. A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis. Aliment Pharmacol Ther 2005;21:899-907. (Pubitemid 40477250)
-
(2005)
Alimentary Pharmacology and Therapeutics
, vol.21
, Issue.7
, pp. 899-907
-
-
De Wet, N.T.E.1
Bester, A.J.2
Viljoen, J.J.3
Filho, F.4
Suleiman, J.M.5
Ticona, E.6
Llanos, E.A.7
Fisco, C.8
Lau, W.9
Buell, D.10
-
27
-
-
8744314133
-
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation
-
DOI 10.1086/422312
-
van Burik JA, Ratanatharathorn V, Stepan DE, et al. Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. Clin Infect Dis 2004;39:1407-16. (Pubitemid 39518200)
-
(2004)
Clinical Infectious Diseases
, vol.39
, Issue.10
, pp. 1407-1416
-
-
Van Burik, J.-A.H.1
Ratanatharathorn, V.2
Stepan, D.E.3
Miller, C.B.4
Lipton, J.H.5
Vesole, D.H.6
Bunin, N.7
Wall, D.A.8
Hiemenz, J.W.9
Satoi, Y.10
Lee, J.M.11
Walsh, T.J.12
-
28
-
-
23044499954
-
Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers: Report of three cases and literature review
-
DOI 10.1097/01.ico.0000154390.28254.54
-
Matsumoto Y, Dogru M, Goto E, et al. Successful topical application of a new antifungal agent, micafungin, in the treatment of refractory fungal corneal ulcers. Cornea 2005;24:748-53. (Pubitemid 41060940)
-
(2005)
Cornea
, vol.24
, Issue.6
, pp. 748-753
-
-
Matsumoto, Y.1
Dogru, M.2
Goto, E.3
Fujishima, H.4
Tsubota, K.5
-
30
-
-
0027417871
-
Postoperative candida keratitis treated successfully with fluconazole [2]
-
Holgado S, Luna JD, Juarez CP. Postoperative Candida keratitis treated successfully with fluconazole. Ophthalmic Surg 1993;24:132. (Pubitemid 23088560)
-
(1993)
Ophthalmic Surgery
, vol.24
, Issue.2
, pp. 132
-
-
Holgado, S.1
Luna, J.D.2
Juarez, C.P.3
-
31
-
-
34147142297
-
Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits
-
DOI 10.1097/ICO.0b013e31802cd8a8, PII 0000322620070400000017
-
Hiraoka T, Kaji Y, Wakabayashi T, et al. Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits. Cornea 2007;26:336-42. (Pubitemid 46568835)
-
(2007)
Cornea
, vol.26
, Issue.3
, pp. 336-342
-
-
Hiraoka, T.1
Kaji, Y.2
Wakabayashi, T.3
Nanbu, P.N.4
Okamoto, F.5
Oshika, T.6
-
32
-
-
0037224012
-
Candida Parapsilosis keratitis
-
DOI 10.1097/00003226-200301000-00012
-
Bourcier T, Touzeau O, Thomas F, et al. Candida parapsilosis keratitis. Cornea 2003;22:51-5. (Pubitemid 36076682)
-
(2003)
Cornea
, vol.22
, Issue.1
, pp. 51-55
-
-
Bourcier, T.1
Touzeau, O.2
Thomas, F.3
Chaumeil, C.4
Baudrimont, M.5
Borderie, V.6
Laroche, L.7
-
33
-
-
1242307500
-
National surveillance of species distribution in blood isolates of Candida species in Japan and thier susceptibility to six antifungal agents including voriconazole and micafungin
-
DOI 10.1093/jac/dkh053
-
Takakura S, Fujihara N, Saito T, et al. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother 2004;53:283-9. (Pubitemid 38239963)
-
(2004)
Journal of Antimicrobial Chemotherapy
, vol.53
, Issue.2
, pp. 283-289
-
-
Takakura, S.1
Fujihara, N.2
Saito, T.3
Kudo, T.4
Iinuma, Y.5
Ichiyama, S.6
-
34
-
-
17744375967
-
Toxicological evaluation of micafungin ophthalmic solution in rabbit eyes
-
DOI 10.1089/jop.2005.21.149
-
Hiraoka T, Wakabayashi T, Kaji Y, et al. Toxicological evaluation of micafungin ophthalmic solution in rabbit eyes. J Ocul Pharmacol Ther 2005;21:149-56. (Pubitemid 40577970)
-
(2005)
Journal of Ocular Pharmacology and Therapeutics
, vol.21
, Issue.2
, pp. 149-156
-
-
Hiraoka, T.1
Wakabayashi, T.2
Kaji, Y.3
Nanbu, P.N.4
Okamoto, F.5
Kiuchi, T.6
Fu, B.7
Oshika, T.8
-
35
-
-
16244388219
-
Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model
-
DOI 10.1128/AAC.49.4.1359-1363.2005
-
Goldblum D, Frueh BE, Sarra GM, et al. Topical caspofungin for treatment of keratitis caused by Candida albicans in a rabbit model. Antimicrob Agents Chemother 2005;49:1359-63. (Pubitemid 40463362)
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, Issue.4
, pp. 1359-1363
-
-
Goldblum, D.1
Frueh, B.E.2
Sarra, G.-M.3
Katsoulis, K.4
Zimmerli, S.5
-
36
-
-
7644239798
-
Potential use of (1,3)-beta-D-glucan as target of diagnosis and treatment of keratomycosis
-
Kaji Y, Hiraoka T, Oshika T. Potential use of (1,3)-beta-D-glucan as target of diagnosis and treatment of keratomycosis. Cornea 2004;23:S36-41. (Pubitemid 39458542)
-
(2004)
Cornea
, vol.23
, Issue.8 SUPPL.
-
-
Kaji, Y.1
Hiraoka, T.2
Oshika, T.3
-
37
-
-
32344440108
-
Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant candida spp.
-
DOI 10.1128/JCM.44.2.324-326.2006
-
Messer SA, Diekema DJ, Boyken L, et al. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp. J Clin Microbiol 2006;44:324-6. (Pubitemid 43222217)
-
(2006)
Journal of Clinical Microbiology
, vol.44
, Issue.2
, pp. 324-326
-
-
Messer, S.A.1
Diekema, D.J.2
Boyken, L.3
Tendolkar, S.4
Hollis, R.J.5
Pfaller, M.A.6
-
38
-
-
0036230264
-
Micafungin sodium (FK-463)
-
DOI 10.1358/dot.2002.38.4.820091
-
Fromtling RA. Micafungin sodium (FK-463). Drugs Today 2002;4:245-57. (Pubitemid 34429288)
-
(2002)
Drugs of Today
, vol.38
, Issue.4
, pp. 245-257
-
-
Fromtling, R.A.1
-
39
-
-
0035215090
-
Clinical efficacy of echinocandin antifungals
-
Arathoon EG. Clinical efficacy of echinocandin antifungals. Curr Opin Infect Dis 2001;14:685-91. (Pubitemid 33141188)
-
(2001)
Current Opinion in Infectious Diseases
, vol.14
, Issue.6
, pp. 685-691
-
-
Arathoon, E.G.1
-
40
-
-
17744404136
-
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis
-
DOI 10.1128/AAC.44.3.614-618.2000
-
Ikeda F, Wakai Y, Matsumoto S, et al. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis. Antimicrob Agents Chemother 2000;44:614-18. (Pubitemid 30117950)
-
(2000)
Antimicrobial Agents and Chemotherapy
, vol.44
, Issue.3
, pp. 614-618
-
-
Ikeda, F.1
Wakai, Y.2
Matsumoto, S.3
Maki, K.4
Watabe, E.5
Tawara, S.6
Goto, T.7
Watanabe, Y.8
Matsumoto, F.9
Kuwahara, S.10
|